Offerings // Grace Therapeutics, Inc.

GRCE offering history

Every offering-related filing in Grace Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 594 filings back to Sep 2, 2008.

Last executed offering
Aug 6, 2026
8-K — priced deal (shares or notes)
Last registration (announced)
Aug 24, 2026
S-3 — capacity, not a sale
Executed, last 12 months
1
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Aug 31, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 24, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Aug 6, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 13, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 10, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Feb 10, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Oct 15, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 15, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 7, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Aug 2, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 16, 2023424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Oct 16, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 6, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Sep 26, 20238-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jun 23, 2022424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Nov 10, 2021424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 15, 2021424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 15, 2021EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 7, 2020424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 7, 2020EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 29, 2020S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Aug 9, 2019EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 7, 2019F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Jul 17, 2019EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 14, 2019424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 17, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Oct 5, 2018424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Oct 3, 2018424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 16, 2018EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 6, 2018F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Feb 15, 2018424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jan 18, 2018424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Dec 22, 2017424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Dec 19, 2017F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Dec 19, 2017EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Dec 18, 2017F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Dec 15, 2017F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 29, 2017F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 24, 2017F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 24, 2017FWP →MARKETINGFree-writing prospectus — offering being marketed
GRCE offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full GRCE workspace →
GRCE offering FAQ

When did GRCE last execute an offering?

Per SEC filings, Grace Therapeutics, Inc.'s most recent priced offering document is a 8-K filed 2026-08-06. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did GRCE last announce or register an offering?

The most recent registration is a S-3 filed 2026-08-24. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.